Brick Laboratories (Unani), a phytopharmaceuticals equipped with state of the art manufacturing unit, in compliance with GMP; implementing all modern advancements, marketing its products ethically which means prescription sale only. Brick Laboratories has recently been issued “Form 6” and enlisted as “manufacturer” with the Drug Regulatory Authority of Pakistan, in its way to the registration with the Ministry of Health, Pakistan.

In 1969, apt. Drs. Rudy Soetikno, a young pharmacist serving in the Indonesian Army, noted the scarce supply of medicine around him. To alleviate this situation, he decided to utilise his knowledge of medicine, setting up a small pharmacy with friends to produce tablets. This small pharmacy rapidly acquired a reputation for producing highly effective prescription drugs, facilitating its expansion into other pharmaceuticals, facilities, and markets. By 1978, its products were available across all parts of Indonesia. Its name, “Dexa”, was derived from the Greek word for ten, a symbol of perfection.
Thus began Dexa Group, now among Southeast Asia’s largest pharmaceutical providers and a key strategic asset for Indonesia. The group applies its expertise in discovery, formulation, manufacturing, and marketing to supply highly sophisticated pharmaceuticals, nutraceuticals, supplements, and herbal medicines throughout Southeast Asia. It still maintains its trademark relentless emphasis on producing medicines of the highest quality. In fact, Dexa Group also works closely with the Indonesian Pharmaceutical Association to improve compliance standards across the entire industry.

East African India Overseas is an Indian Pharmaceutical Conglomerate, Manufacturing & Exporting healthcare products in 40 Countries worldwide, covering the Market like Africa, South-East Asia, Central Asia, Central America & the Middle East. These are a 43-year-old manufacturing company. They provide contract manufacturing services to numerous companies, including Sun Pharma, Wokhardt, Alkem, Abbott, Ajanta, Alembic, Cipla, Cadila, DRL, Elder, Glenmark, Intas, Lupin and Zydus Cadila.

Egyptian International Pharmaceutical Industries Co. (EIPICO) is the Leading Egyptian Pharmaceutical Company, in Production, by Units. It produces 400 Pharmaceutical Products covering 25 therapeutic classes and it is the Major Provider of Antibiotics, Lyophilized products and Spansule Capsules, to the Egyptian market. EIPICO also produces the non-traditional dosage forms such as the soft gelatin capsules, lyophilized products, gels, sprayers and effervescent tablets. The sound management enables EIPICO to seek the highest quality of raw material from the least expensive sources.

FIPCO pharmaceuticals are an Egyptian pharmaceutical manufacturers specialized in the production of sterile dosage forms mainly intravenous infusions and water for injections. They also produce non-sterile dosage forms like hemodialysis solutions, sodium bicarbonate sachets and purified water solvent.